Ligand profile
CHEMBL178091
Bioactivity hit from ChEMBL on a similar protein.
Bound to: VK055_2384 — methionine aminopeptidase, type I
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL178091- UniProt (similar protein)
P0AE18- pchembl
- 7.130 (~74.1 nM)
- Target protein
- VK055_2384
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 64.1
- −1 ≤ LogP ≤ 5 2.43
- MW ≤ 500 Da 283.4
- LogP ≤ 5 2.43
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 64.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
COC(C)Cc1scnc1C(=O)Nc1nccs1COC(C)Cc1scnc1C(=O)Nc1nccs1
InChI=1S/C11H13N3O2S2/c1-7(16-2)5-8-9(13-6-18-8)10(15)14-11-12-3-4-17-11/h3-4,6-7H,5H2,1-2H3,(H,12,14,15)InChI=1S/C11H13N3O2S2/c1-7(16-2)5-8-9(13-6-18-8)10(15)14-11-12-3-4-17-11/h3-4,6-7H,5H2,1-2H3,(H,12,14,15)
KZEVEDBAQBDXNN-UHFFFAOYSA-NKZEVEDBAQBDXNN-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- ChEMBL
- Binding sites
- PF00557
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL178091 →
- UniProt UniProt P0AE18 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL178091”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2384.
PDB 46
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).